Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parikh

Showing results (941-950 of 1,087) with videos related to

Pageof 109
Sort By:
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate CancerNeil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
Kidney360|April 4, 2022
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter StudyRubab F Malik, Yaqi Jia, Sherry G Mansour, et al.
Kidney International Reports|July 9, 2025
The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse OutcomesYumeng Wen, Nityasree Srialluri, Danielle Farrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2020
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney InjurySandeep Brar, Kathleen D Liu, Alan S Go, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
JCI Insight|May 11, 2021
Urinary EGF and MCP-1 and risk of CKD after cardiac surgerySteven Menez, Wenjun Ju, Rajasree Menon, et al.
BMC Nephrology|April 4, 2014
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysisMitesh Shah, Arsh K Jain, Steven M Brunelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 30, 2018
Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate InitiationSimon B Ascher, Rebecca Scherzer, Michelle M Estrella, et al.
The New England Journal of Medicine|February 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in <i>TP53</i> Y220C-Mutated TumorsEcaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh, et al.
Pageof 109

Showing results (941-950 of 1,087) with videos related to

Sort By:
Pageof 109
International Journal of Radiation Oncology, Biology, Physics|June 17, 2020
Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate CancerNeil R Parikh, Eric M Chang, Nicholas G Nickols, et al.
Kidney360|April 4, 2022
Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter StudyRubab F Malik, Yaqi Jia, Sherry G Mansour, et al.
Kidney International Reports|July 9, 2025
The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse OutcomesYumeng Wen, Nityasree Srialluri, Danielle Farrington, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2020
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney InjurySandeep Brar, Kathleen D Liu, Alan S Go, et al.
The Oncologist|October 31, 2018
Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.
Annals of Internal Medicine|April 2, 2003
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathyTomas Berl, Lawrence G Hunsicker, Julia B Lewis, et al.
JCI Insight|May 11, 2021
Urinary EGF and MCP-1 and risk of CKD after cardiac surgerySteven Menez, Wenjun Ju, Rajasree Menon, et al.
BMC Nephrology|April 4, 2014
Association between angiotensin converting enzyme inhibitor or angiotensin receptor blocker use prior to major elective surgery and the risk of acute dialysisMitesh Shah, Arsh K Jain, Steven M Brunelli, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 30, 2018
Association of Urinary Biomarkers of Kidney Injury with Estimated GFR Decline in HIV-Infected Individuals following Tenofovir Disoproxil Fumarate InitiationSimon B Ascher, Rebecca Scherzer, Michelle M Estrella, et al.
The New England Journal of Medicine|February 25, 2026
Phase 1 Study of Rezatapopt, a p53 Reactivator, in <i>TP53</i> Y220C-Mutated TumorsEcaterina E Dumbrava, Geoffrey I Shapiro, Aparna R Parikh, et al.
Pageof 109